Privia Health (PRVA) EV to EBITDA (2021 - 2026)

Privia Health has reported EV to EBITDA for 6 years, with the latest figure at 242.74 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 65.55% year-over-year to 242.74 in Q2 2026; TTM through Jun 2026 was 63.59, a 47.35% decrease from a year earlier, with the FY2025 full-year figure at 71.62, down 32.16% from the prior year.
• EV to EBITDA was 242.74 for Q2 2026 at Privia Health, down from 293.17 in the prior quarter.
• The five-year high for EV to EBITDA was 1808.24 in Q1 2024, with the low at 839.96 in Q3 2022.
• Average EV to EBITDA over 5 years is 371.01, with a median of 335.52 recorded in 2024.
• The largest YoY upside for EV to EBITDA was 785.0% in 2022 against a maximum downside of 2498.72% in 2022.
• Over 5 years, EV to EBITDA stood at 895.59 in 2022, then jumped by 54.8% to 1386.35 in 2023, then slumped by 74.85% to 348.64 in 2024, then plunged by 37.18% to 219.0 in 2025, then increased by 10.84% to 242.74 in 2026.
• The last three EV to EBITDA figures came in at 242.74 (Q2 2026), 293.17 (Q1 2026), and 219.0 (Q4 2025), per Business Quant data.